Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume.

Carmichael O, Xie J, Fletcher E, Singh B, DeCarli C; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2012 Jun;33(6):1124.e31-41. doi: 10.1016/j.neurobiolaging.2011.08.016. Epub 2011 Dec 14.

2.

MRI and CSF studies in the early diagnosis of Alzheimer's disease.

de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H.

J Intern Med. 2004 Sep;256(3):205-23.

3.

ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.

Apostolova LG, Hwang KS, Kohannim O, Avila D, Elashoff D, Jack CR Jr, Shaw L, Trojanowski JQ, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage Clin. 2014 Jan 4;4:461-72. doi: 10.1016/j.nicl.2013.12.012. eCollection 2014.

4.

Hippocampal subregions are differentially affected in the progression to Alzheimer's disease.

Greene SJ, Killiany RJ; Alzheimer's Disease Neuroimaging Initiative.

Anat Rec (Hoboken). 2012 Jan;295(1):132-40. doi: 10.1002/ar.21493. Epub 2011 Nov 18.

5.

Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.

Henneman WJ, Sluimer JD, Barnes J, van der Flier WM, Sluimer IC, Fox NC, Scheltens P, Vrenken H, Barkhof F.

Neurology. 2009 Mar 17;72(11):999-1007. doi: 10.1212/01.wnl.0000344568.09360.31.

6.

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.

Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2010 Nov;133(11):3336-48. doi: 10.1093/brain/awq277. Epub 2010 Oct 8.

7.

Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R, Stern Y, Tabert MH, de Leon MJ.

Neurology. 2007 Mar 13;68(11):828-36.

PMID:
17353470
8.

Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition.

Vemuri P, Weigand SD, Przybelski SA, Knopman DS, Smith GE, Trojanowski JQ, Shaw LM, Decarli CS, Carmichael O, Bernstein MA, Aisen PS, Weiner M, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2011 May;134(Pt 5):1479-92. doi: 10.1093/brain/awr049. Epub 2011 Apr 7.

9.

CSF biomarker associations with change in hippocampal volume and precuneus thickness: implications for the Alzheimer's pathological cascade.

Stricker NH, Dodge HH, Dowling NM, Han SD, Erosheva EA, Jagust WJ; Alzheimer’s Disease Neuroimaging Initiative.

Brain Imaging Behav. 2012 Dec;6(4):599-609. doi: 10.1007/s11682-012-9171-6.

10.

Neuropathologic correlates of hippocampal atrophy in the elderly: a clinical, pathologic, postmortem MRI study.

Dawe RJ, Bennett DA, Schneider JA, Arfanakis K.

PLoS One. 2011;6(10):e26286. doi: 10.1371/journal.pone.0026286. Epub 2011 Oct 17.

11.

Association between NME8 locus polymorphism and cognitive decline, cerebrospinal fluid and neuroimaging biomarkers in Alzheimer's disease.

Liu Y, Yu JT, Wang HF, Hao XK, Yang YF, Jiang T, Zhu XC, Cao L, Zhang DQ, Tan L.

PLoS One. 2014 Dec 8;9(12):e114777. doi: 10.1371/journal.pone.0114777. eCollection 2014.

12.

Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease.

Mueller SG, Schuff N, Yaffe K, Madison C, Miller B, Weiner MW.

Hum Brain Mapp. 2010 Sep;31(9):1339-47. doi: 10.1002/hbm.20934.

13.

Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.

Jack CR Jr, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC.

Neurology. 2004 Feb 24;62(4):591-600.

14.

Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.

Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM.

Arch Neurol. 2006 May;63(5):693-9. Erratum in: Arch Neurol. 2007 Sep;64(9):1360-1.

PMID:
16682538
15.

Hippocampal Subfield Volumetry and 3D Surface Mapping in Subjective Cognitive Decline.

Perrotin A, de Flores R, Lamberton F, Poisnel G, La Joie R, de la Sayette V, Mézenge F, Tomadesso C, Landeau B, Desgranges B, Chételat G.

J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S141-50. doi: 10.3233/JAD-150087.

PMID:
26402076
16.

Semantic memory activation in amnestic mild cognitive impairment.

Woodard JL, Seidenberg M, Nielson KA, Antuono P, Guidotti L, Durgerian S, Zhang Q, Lancaster M, Hantke N, Butts A, Rao SM.

Brain. 2009 Aug;132(Pt 8):2068-78. doi: 10.1093/brain/awp157. Epub 2009 Jun 10.

17.

The dynamics of cortical and hippocampal atrophy in Alzheimer disease.

Sabuncu MR, Desikan RS, Sepulcre J, Yeo BT, Liu H, Schmansky NJ, Reuter M, Weiner MW, Buckner RL, Sperling RA, Fischl B; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2011 Aug;68(8):1040-8. doi: 10.1001/archneurol.2011.167.

18.

Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease.

Leung KK, Barnes J, Ridgway GR, Bartlett JW, Clarkson MJ, Macdonald K, Schuff N, Fox NC, Ourselin S; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 Jul 15;51(4):1345-59. doi: 10.1016/j.neuroimage.2010.03.018. Epub 2010 Mar 15.

19.

Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease.

Mungas D, Reed BR, Jagust WJ, DeCarli C, Mack WJ, Kramer JH, Weiner MW, Schuff N, Chui HC.

Neurology. 2002 Sep 24;59(6):867-73.

20.

Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta-analyses of MRI studies.

Shi F, Liu B, Zhou Y, Yu C, Jiang T.

Hippocampus. 2009 Nov;19(11):1055-64. doi: 10.1002/hipo.20573.

PMID:
19309039

Supplemental Content

Support Center